Workflow
商品流通
icon
Search documents
南京新百:12月17日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-12-17 11:32
每经AI快讯,南京新百(SH 600682,收盘价:8.27元)12月17日晚间发布公告称,公司第十一届第一 次董事会会议于2025年12月17日以现场表决和通讯表决相结合的方式召开。会议审议了《关于聘任公司 证券事务代表的议案》等文件。 2025年1至6月份,南京新百的营业收入构成为:健康养老和护理行业占比33.68%,医药制造业占比 23.16%,专业技术服务业占比15.25%,医疗服务占比14.61%,商品流通业占比5.89%。 截至发稿,南京新百市值为111亿元。 每经头条(nbdtoutiao)——海南封关政策红利全解析:零关税、低个税、投资准入放宽、跨境资金自 由、创业扶持…… (记者 张明双) ...
南京新百:11月28日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-12-01 11:46
每经头条(nbdtoutiao)——5年期大面积下线,3年期利率低至1.5%仍一单难求:要么"售罄"要么"额度 紧张"!中长期大额存单为何在消失? (记者 曾健辉) 每经AI快讯,南京新百(SH 600682,收盘价:7.82元)12月1日晚间发布公告称,公司第十届第二十三 次董事会会议于2025年11月28日以通讯表决的方式召开。会议审议了《关于修订 <董事会审计委员会工 作细则> 的议案》等文件。 2025年1至6月份,南京新百的营业收入构成为:健康养老和护理行业占比33.68%,医药制造业占比 23.16%,专业技术服务业占比15.25%,医疗服务占比14.61%,商品流通业占比5.89%。 截至发稿,南京新百市值为105亿元。 ...
苏豪时尚:拟出售所持部分南京聚隆A股股票
Mei Ri Jing Ji Xin Wen· 2025-10-10 12:19
Core Viewpoint - Suhao Fashion announced plans to optimize its asset structure by selling part of its stock holdings in Nanjing Julong, with a maximum of 5.5 million shares to be sold within 12 months from the board's approval date [1] Group 1: Company Actions - The board of Suhao Fashion unanimously approved the proposal to sell part of its stock assets to focus on core business development [1] - The management is authorized to determine the specific timing, trading method, quantity, and price of the sale based on market conditions [1] Group 2: Financial Performance - For the first half of 2025, Suhao Fashion's revenue composition was as follows: 91.44% from merchandise circulation, 6.23% from clothing processing, 1.55% from other businesses, and 0.77% from chemical warehousing [1] - As of the report date, Suhao Fashion's market capitalization stood at 2.5 billion yuan [1]
南京新百:公司拟减持不超过600万股的已回购股份
Mei Ri Jing Ji Xin Wen· 2025-08-20 10:20
Group 1 - The company Nanjing Xinbai plans to reduce its repurchased shares by up to 6 million shares, accounting for 0.45% of its total share capital, through centralized bidding trading starting 15 trading days after the announcement until September 26, 2025 [1] - The company will adjust the number of shares to be reduced if there are changes in the number of shares due to stock dividends or capital reserve transfers during this period [1] - After the sale of the repurchased shares, the remaining shares will be arranged for cancellation as per the repurchase plan [1] Group 2 - For the year 2024, the revenue composition of Nanjing Xinbai is as follows: health and elderly care industry 31.77%, pharmaceutical manufacturing 24.3%, professional technical services 17.41%, medical services 13.59%, and commodity circulation 6.14% [1] - As of the report, the market capitalization of Nanjing Xinbai is 11.9 billion yuan [1]
600287,摘帽!停牌
Core Viewpoint - ST Shuntian (600287) has successfully removed the risk warning label and will resume trading under the name Jiangsu Shuntian starting July 16, 2024, following a self-assessment confirming compliance with the conditions for removal [1][2]. Group 1: Stock and Trading Information - The stock will be suspended for one day on July 15, 2024, and will resume trading with a change in the daily price fluctuation limit from 5% to 10% [1]. - The company was under risk warning due to an administrative penalty from the China Securities Regulatory Commission, which has now been resolved [1]. Group 2: Financial Adjustments and Liabilities - The company has corrected accounting errors and restated financial reports for the years 2009-2021 and the balance sheets for 2009-2022 and Q3 2023 [1]. - As of the announcement date, the company has recognized a provision for investor claims amounting to 3.77 million yuan, with an estimated liability of 331.20 million yuan recorded in the 2024 annual report [2]. Group 3: Business Segments and Revenue - The company's main business segments include commodity circulation, garment processing, and chemical warehousing, generating revenues of 3.069 billion yuan, 124 million yuan, and 20 million yuan respectively in 2024 [2]. - The gross profit margins for these segments are 14%, 3.56%, and 16.81% respectively, with domestic revenue at 1.203 billion yuan and overseas revenue at 2.009 billion yuan [2]. Group 4: Recent Performance - In Q1 2025, the company reported a revenue of 643 million yuan and a net profit attributable to shareholders of 8.27 million yuan [3].